Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Loss of type I IFN responsiveness impairs natural killer cell antitumor activity in breast cancer
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-15
DOI
10.1007/s00262-021-02857-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate cancer cell‐intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone
- (2020) Katie L Owen et al. EMBO REPORTS
- NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists
- (2020) Christopher J. Nicolai et al. Science Immunology
- Antagonism of IAPs enhances CAR T cell efficacy
- (2019) Jessica Michie et al. Cancer Immunology Research
- Sustained Type I Interferon Reinforces NK Cell–Mediated Cancer Immunosurveillance during Chronic Virus Infection
- (2019) Ji Hoon Oh et al. Cancer Immunology Research
- A gene signature predicting natural killer cell infiltration and improved survival in melanoma patients
- (2019) Joseph Cursons et al. Cancer Immunology Research
- Progressive Impairment of NK Cell Cytotoxic Degranulation Is Associated With TGF-β1 Deregulation and Disease Progression in Pancreatic Cancer
- (2019) Eunsung Jun et al. Frontiers in Immunology
- Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes
- (2019) Chunwan Lu et al. Journal for ImmunoTherapy of Cancer
- Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
- (2019) Nicolas Jacquelot et al. CELL RESEARCH
- JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
- (2019) Katie L. Owen et al. Cancers
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis
- (2018) Peter Savas et al. NATURE MEDICINE
- Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance
- (2018) Megha Budhwani et al. Frontiers in Oncology
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8+ T Cells
- (2018) Abena K. R. Kwaa et al. JOURNAL OF VIROLOGY
- VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
- (2017) Jianjun Gao et al. NATURE MEDICINE
- Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
- (2017) Meredith L. Stone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neoadjuvant Interferons: Critical for Effective PD-1–Based Immunotherapy in TNBC
- (2017) Natasha K. Brockwell et al. Cancer Immunology Research
- Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis
- (2017) Eva M. Putz et al. OncoImmunology
- Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications
- (2017) Martina Musella et al. OncoImmunology
- Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
- (2016) Andy J. Minn et al. CELL
- In Vivo Visualizing the IFN-β Response Required for Tumor Growth Control in a Therapeutic Model of Polyadenylic-Polyuridylic Acid Administration
- (2016) David Andrés Nocera et al. JOURNAL OF IMMUNOLOGY
- NK Cells Restrain Spontaneous Antitumor CD8+T Cell Priming through PD-1/PD-L1 Interactions with Dendritic Cells
- (2016) Ximena L. Raffo Iraolagoitia et al. JOURNAL OF IMMUNOLOGY
- Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
- (2016) Yuliya V. Katlinskaya et al. Cell Reports
- STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia
- (2016) Emily Curran et al. Cell Reports
- Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer
- (2015) C. N. Johnstone et al. Disease Models & Mechanisms
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- NK cells regulating T cell responses: mechanisms and outcome
- (2015) Josh Crouse et al. TRENDS IN IMMUNOLOGY
- Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer
- (2015) Christine Pasero et al. Oncotarget
- Loss of Host Type-I IFN Signaling Accelerates Metastasis and Impairs NK-cell Antitumor Function in Multiple Models of Breast Cancer
- (2015) J. Rautela et al. Cancer Immunology Research
- B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape
- (2015) Silvia Pesce et al. OncoImmunology
- Loss of STAT1 from Mouse Mammary Epithelium Results in an Increased Neu-Induced Tumor Burden
- (2015) Peter J. Klover et al. NEOPLASIA
- Type I Interferon Protects Antiviral CD8+ T Cells from NK Cell Cytotoxicity
- (2014) Haifeng C. Xu et al. IMMUNITY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- Role of Type I Interferon Receptor Signaling on NK Cell Development and Functions
- (2014) Jean Guan et al. PLoS One
- Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response
- (2014) P. Kvistborg et al. Science Translational Medicine
- Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells
- (2014) Priyanka Sathe et al. Nature Communications
- Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
- (2014) T. Bald et al. Cancer Discovery
- Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes)
- (2013) Theresa L. Whiteside BIOCHEMICAL SOCIETY TRANSACTIONS
- Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment
- (2013) Taryn L. Green et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures
- (2013) Jérôme Galon et al. IMMUNITY
- Hope and Fear for Interferon: The Receptor-Centric Outlook on the Future of Interferon Therapy
- (2013) Serge Y. Fuchs JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Regulation of murine natural killer cell commitment
- (2013) Nicholas D. Huntington et al. Frontiers in Immunology
- Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells
- (2012) Keiko Kajitani et al. BREAST CANCER RESEARCH AND TREATMENT
- Impaired IFN- Production by Plasmacytoid Dendritic Cells Favors Regulatory T-cell Expansion That May Contribute to Breast Cancer Progression
- (2012) V. Sisirak et al. CANCER RESEARCH
- An optimized method for establishing high purity murine CD8+ T cell cultures
- (2012) Damien Zanker et al. JOURNAL OF IMMUNOLOGICAL METHODS
- The Depletion of NK Cells Prevents T Cell Exhaustion to Efficiently Control Disseminating Virus Infection
- (2012) K. D. Cook et al. JOURNAL OF IMMUNOLOGY
- Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
- (2012) Bradley N Bidwell et al. NATURE MEDICINE
- INTERFEROME v2.0: an updated database of annotated interferon-regulated genes
- (2012) Irina Rusinova et al. NUCLEIC ACIDS RESEARCH
- Natural killer lytic-associated molecule plays a role in controlling tumor dissemination and metastasis
- (2012) Richard G. Hoover et al. Frontiers in Immunology
- Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillance
- (2012) Tatsuaki Mizutani et al. OncoImmunology
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
- (2011) Nicolas F Delahaye et al. NATURE MEDICINE
- Impaired NK Cytolytic Activity and Enhanced Tumor Growth in NK Lytic-Associated Molecule-Deficient Mice
- (2009) R. G. Hoover et al. JOURNAL OF IMMUNOLOGY
- Impaired interferon signaling is a common immune defect in human cancer
- (2009) R. J. Critchley-Thorne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started